BLOG

November 15, 2017 | no comments | Article Blog | by: ian@overhoff.com

US Nuclear Corp signs letter of intent to manufacture MIFTEC medical isotope generators

by John Fischer , Staff Reporter

The radiation detection holding company signed a letter of intent last week with MIFTEC, whose parent company is Magneto-Inertial Fusion Technologies Inc. (MIFTI) Nuclear Fusion, for the sole manufacturing rights of its generators. These utilize its Staged Z-Pinch fusion technique to produce a high number of neutrons, which can then be used to create medical isotopes. “One of the reasons that we’re so excited to be constructing this agreement is that MIFTI and MIFTEC have developed a procedure for producing a large flux of neutrons from a very small footprint,” Robert I. Goldstein, president, CEO and chairman of US Nuclear Corp, told HCB News. “The plan is to build these radioisotope generators and sell them for maybe $6-$10 million each. If you want to put up a nuclear reactor, you’re talking hundreds of millions of dollars to make the initial investment.”

____________________________

To learn more about us visit our about or Facebook page.

Health care currently faces risks of shortages in isotopes, preventing millions of patients from undergoing diagnostic scans and treatment. The situation is partly due to shortages and deteriorating sources of these substances from Russia, Belgium, Canada and South Africa, with the number of nuclear reactors globally few and far between, and existing ones aged. No manufacturers or suppliers exist in the U.S., partially due to strict rules and the need to obtain various forms of permission, according to Goldstein.

The concept of Staged Z-Pinch fusion consists of a zeta pinch, a type of plasma confinement system that uses an electrical current in the plasma to generate a magnetic field. The magnetic field and a shock wave compress the gasses in the system, in which an outpouring of neutrons derive from and instigate the transmutation of isotopes, thereby creating radioisotopes.

MIFTI’s version of the Staged Z-Pinch fusion technique may produce fusion energy, which is fueled by hydrogen. Fusion power is expected to be cleaner and more affordable compared to fission power, which is derived from uranium and plutonium and is the main source behind the production of current medical radioisotopes.

Advanced Research Projects Agency-Energy (ARPA-E), a U.S. government branch tasked with funding research and development of advanced early technologies, has recognized and awarded MIFTI for its approach and quick progression toward fusion energy by providing a nearly limitless supply of clean, domestic power.

MIFTEC and US Nuclear Corp believe that using the system will cut the current cost of producing radioisotopes by fifty percent or more, enabling greater access among individuals to medical isotope diagnostics and treatment, and potentially putting an end to the shortage.

“We’re going to be able to make pretty much every different isotope,” said Goldstein. “One of the beauties of our system is that all the neutrons come out of the same energy, and with filtration we can bring that energy down near the excitation energy required for each different nuclide that somebody wants. With a reactor, it’s just random. You get high energy, low energy. With ours, you get a fixed energy, and using filters, we can lower that to precisely the excitation energy that we’re looking for.”

The signing also grants US Nuclear Corp a ten percent stake in MIFTEC Inc., as well as an option to buy a higher portion of the company in the future.

A final agreement is expected to be completed in January 2018.

Click here for full article.

CONTACT:

US Nuclear Corp. (OTCBB: UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Rachel Boulds, Chief Financial Officer
(818) 883 7043
Email: info@usnuclearcorp.com

____________________________

To learn more about us visit our about or Facebook page.

October 14, 2017 | no comments | Article Blog | by: ian@overhoff.com

Los Angeles, CA. October 16, 2017 - US Nuclear Corp. (OTCBB: UCLE)

 

US Nuclear Corp is preparing to make the first partial shipment of portable tritium air monitors to be used by the U.S. Air Force. The first shipment will consist of (10) units, and is scheduled to be delivered by October 31, 2017. The total contract of $722,500 is for (100) units total, and additional partial shipments of (15) units have been scheduled every month until the quota is met next March, 2018.

“We are very eager and excited to make our first shipment of tritium monitors for the USAF,” remarked Robert Goldstein, President and CEO of US Nuclear Corp. “This order represents a sizeable quantity for us, but we were able to smoothly accommodate the large quantity due to our organized quality management system. We successfully allocated our production schedule so that we can steadily produce 15 units to be shipped every month, while simultaneously completing all other current jobs on the backlog. The prepaid partial shipments every month will continue to produce a steady stream of cashflow for a strong finish in 2017.”

US Nuclear Corp’s portable tritium in air monitors are also used by other government agencies such as the US Army, US Navy, French Navy, NASA, NIST (National Institute of Standards and Technology), EPA (Environmental Protection Agency), and (IAEA) International Atomic Energy Agency.

  

CONTACT:

US Nuclear Corp. (OTCBB: UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Rachel Boulds, Chief Financial Officer
(818) 883 7043
Email: info@usnuclearcorp.com

About US Nuclear Corp.

US Nuclear Corp is a fully-reporting, publicly traded company on the Over-the-Counter Bulletin Board, traded under the ticker symbol UCLE. The Company's operations are principally engaged through its subsidiaries, operating two leading nuclear radiation detection companies, Overhoff Technology Corp. and Optron Scientific Company Inc. The Company designs, manufactures and markets branded, full line radiation detection and specialized advanced tritium technology for the nuclear energy industry and for emerging technological processes such as Thorium and Molten Salt (MSR) reactor technologies both domestically and internationally to customers such as United States Government Agencies, the U.S. Military, Homeland Security, Scientific Laboratories, Universities, Hospitals, nuclear reactor facilities in the United States, China, Canada, South Korea, Argentina, Russia and others.

Safe Harbor Act

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com

CONTACT:

US Nuclear Corp. (OTCBB: UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Rachel Boulds, Chief Financial Officer
(818) 883 7043

____________________________

To learn more about us visit our about or Facebook page.

September 27, 2017 | no comments | Article Blog | by: ian@overhoff.com

Los Angeles, CA. August 23, 2017 - US Nuclear Corp. (OTCBB: UCLE)

  • Sales revenue for the second quarter was $491,436, while Gross Profit was $193,774
  • Net loss for the second quarter was $(127,238)
  • Operating expenses were $315,817, an increase of 33.9% for the same period in 2016
  • Current order backlog of $2,156,679
  • Productive second quarter preparing several large quantity orders for shipment in Q3 and Q4
  • US Nuclear Corp. (OTCBB: UCLE), a leading manufacturer of advanced radiation detection instrumentation, recently announced the financial results for the second quarter ended June 30, 2017.

    “Overall, we had an extremely productive and busy second quarter,” commented Robert I. Goldstein, President, CEO, and Chairman of US Nuclear Corp. “While sales revenue was less than the same period the previous year, we captured important sales opportunities to add to our backlog, while working on finishing production of several substantial quantity orders, which are scheduled to ship in Q3 and Q4. Our cost of sales and operating expenses were higher this period due to the increase in cost of parts required and R&D expenses, but we made excellent progress and will see the results in Q3 and Q4.”

    US Nuclear Corp. is also focusing on adding chemical sensors to their DroneRAD product line, with a number of sales already made. Robert remarked, “The successful integration of chemical sensors to our DroneRAD product line, in addition to our radiation sensors, allows us to greatly broaden our market for DroneRAD applications to reach more potential customers with our phenomenal technology.”

Change Agent Fair

About US Nuclear Corp.

US Nuclear Corp is a fully-reporting, publicly traded company on the Over-the-Counter Bulletin Board, traded under the ticker symbol UCLE. The Company's operations are principally engaged through its subsidiaries, operating two leading nuclear radiation detection companies, Overhoff Technology Corp. and Optron Scientific Company Inc. The Company designs, manufactures and markets branded, full line radiation detection and specialized advanced tritium technology for the nuclear energy industry and for emerging technological processes such as Thorium and Molten Salt (MSR) reactor technologies both domestically and internationally to customers such as United States Government Agencies, the U.S. Military, Homeland Security, Scientific Laboratories, Universities, Hospitals, nuclear reactor facilities in the United States, China, Canada, South Korea, Argentina, Russia and others.

Safe Harbor Act

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com

CONTACT:

US Nuclear Corp. (OTCBB: UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Rachel Boulds, Chief Financial Officer
(818) 883 7043

____________________________

To learn more about us visit our about or Facebook page.

July 14, 2017 | no comments | Article | by: ian@overhoff.com

LOS ANGELES, CA--(Marketwired - May 19, 2017) - US Nuclear Corp. ( OTCBB : UCLE )

  • Sales revenue for the first quarter was $725,472, a 187% increase over the same period in the prior year
  • Gross Profit was $355,072, a 191% increase over the same period in the prior year
  • Net income for the first quarter was $91,233
  • Excellent start for 2017, robust back-log to carry momentum into second quarter

US Nuclear Corp. ( OTCBB : UCLE ), a leading manufacturer of advanced radiation detection instrumentation, issued Form 10-Q on May 15, 2017, in which it announced profitable financial results for the quarter ended March 31, 2017. 

"We are thrilled about our first quarter performance in 2017," commented Robert I. Goldstein, President, CEO, and Chairman of US Nuclear Corp. "We had a very productive start to the year, shipping several large orders that were on our backlog, while simultaneously capturing more sales to carry the momentum forward into the second quarter and position ourselves for an excellent year. We continued to see increasing demand for our DroneRAD product line, with several units currently in production and interest growing daily."

US Nuclear Corp. also opened a new office in Beijing, China during the first quarter of 2017. Robert added, "Technicians and product support specialists for our new office in China completed factory training earlier this year. We have already begun to see an increase in business in China as we are now able to communicate directly and more efficiently and offer local service/support to our customers."

US Nuclear Corp. Reports Strong First Quarter 2017 Results

About US Nuclear Corp.

US Nuclear Corp. is a fully-reporting, publicly traded company on the Over-the-Counter Bulletin Board, traded under the ticker symbol UCLE. The Company's operations are principally engaged through its subsidiaries, operating two leading nuclear radiation detection companies, Overhoff Technology Corp. and Optron Scientific Company Inc. The Company designs, manufactures and markets branded, full line radiation detection and specialized advanced tritium technology for the nuclear energy industry and for emerging technological processes such as Thorium and Molten Salt (MSR) reactor technologies both domestically and internationally to customers such as United States Government Agencies, the U.S. Military, Homeland Security, Scientific Laboratories, Universities, Hospitals, nuclear reactor facilities in the United States, China, Canada, South Korea, Argentina, Russia and others.

Safe Harbor Act

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company's website at www.usnuclearcorp.com

____________________________

To learn more about us visit our about or Facebook page.

June 8, 2017 | no comments | Article Blog | by: ian@overhoff.com

 

Equities Research |
The LD Micro Invitational Conference kicked off yesterday, with Equities.com CEO Enzo Villani giving a keynote address and discussing our new flat monthly rate trading platform. 100 microcap companies will be making 30-minutes presentations throughout today, with another 70 companies slotted for tomorrow.

We've been following a company presenting later this afternoon called US Nuclear Corp (UCLE) that manufactures advanced radiation detection instrumentation. The most recent product development is DroneRad - the incorporation of radiation and chemical sensors with drone mounted platforms to serve a variety of industries. The company has a strategic partnership with FlyCam UAV, announced last fall, that incorporates FlyCam UAV's Cypher 6, a commercial-grade hexacopter, and The NEO, an all-weather commercial co-axial octocopter, with US Nuclear Corp’s DroneRad aerial radiation detection system.

DroneRad detects particles that contain alpha, beta, gamma and neutron radiation. A gas collection option tests for the presence of chlorine, biological particulates, and aerosols such as anthrax and nerve gas, making DroneRad suitable for radiological, chemical and biological detection missions. Future upgrades to the DroneSensor package will detect methane and diesel fumes.to provides a comprehensive package that flies in all-weather, heavy winds, and with a heavy payload. This provides the opportunity to fly multiple sensors at one time with real-time wireless download.

US Nuclear reported revenues of $725,000 in Q1 2017, a 187% increase year-over-year, with gross profit of $355,000 and net income of $91,000. The company, headquartered in Canoga Park, California, opened a new office in Beijing during Q1. CEO Robert Goldstein stated, "Technicians and product support specialists for our new office in China completed factory training earlier this year. We have already begun to see an increase in business in China as we are now able to communicate directly and more efficiently and offer local service/support to our customers."

Mr. Goldstein is a physicist and an award winning specialist in the nuclear radiation detection industry with more than 40 years of experience in the field. He works closely in ongoing joint development programs with Los Alamos National Lab and Jefferson National Lab. An innovator and inventor, his experience in the field of radiation measurement, detection, and monitoring includes design and development of instrumentation for air, water and surface applications. Miniature radiation detectors for use during surgery are just a sample of his many inventions and innovative designs. He graduated from MIT with a BS in Physics and has an MS in Engineering from Stanford.

The stock trades very thinly (11,300 shares over the past month) on the Pink Open Market segment of the OTC Market - which is going to leave it vulnerable to big swings like today - but it is fully reporting and current with the SEC. We've reviewed the recent 10-K for 2016 and 10-Q for the first quarter of 2017, and we see a company growing revenue and expanding to the key Chinese market that is burdened with the discount often associated with non-exchange-listed stocks. Investors who can tolerate the volatility and illiquidity may wish to follow this company along with us.

____________________________

To learn more about us visit our about or Facebook page.

Change Agent Fair